Late Thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: A meta-analysis of randomized and observational studies

JACC: Cardiovascular Interventions

Volumn 6, Issue 7, 2013, Pages 687-695

  Zimarino, Marco ^a   Corazzini, Alessandro ^a   Ricci, Fabrizio ^a   Di Nicola, Marta ^b   De Caterina, Raffaele ^a  

^a Centre of Excellence on Aging   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

coronary bifurcation; drug eluting stent thrombosis; percutaneous coronary intervention

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ARTICLE; CORONARY BIFURCATION LESION; DRUG ELUTING STENT; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT THROMBOSIS; SYSTEMATIC REVIEW;

CI; CONFIDENCE INTERVAL; CORONARY BIFURCATION; DDS; DES; DOUBLE DRUG-ELUTING STENT STRATEGY; DRUG-ELUTING STENT THROMBOSIS; DRUG-ELUTING STENT(S); MI; MYOCARDIAL INFARCTION; NONRANDOMIZED, OBSERVATIONAL STUDY; NROS; PCI; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED, CONTROLLED TRIAL; RCT; RELATIVE RISK; RR; SDS; SINGLE DRUG-ELUTING STENT STRATEGY; TARGET VESSEL REVASCULARIZATION; TVR;

CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; LINEAR MODELS; MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY AS TOPIC; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880271031     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.03.012     Document Type: Article

References (51)

1. T. Lefevre, Y. Louvard, and M.C. Morice Stenting of bifurcation lesions: classification, treatments, and results Catheter Cardiovasc Interv 49 2000 274 283 (Pubitemid 30133517)
2. A. Latib, A. Colombo, and G.M. Sangiorgi Bifurcation stenting: current strategies and new devices Heart 95 2009 495 504
3. M. Pan, J.S. de Lezo, and A. Medina Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy Am Heart J 148 2004 857 864
4. A. Colombo, J.W. Moses, and M.C. Morice Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions Circulation 109 2004 1244 1249 (Pubitemid 38372783)
5. T.K. Steigen, M. Maeng, and R. Wiseth Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study Circulation 114 2006 1955 1961 (Pubitemid 44665390)
6. M. Ferenc, M. Gick, and R.P. Kienzle Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions Eur Heart J 29 2008 2859 2867
7. A. Colombo, E. Bramucci, and S. Sacca Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study Circulation 119 2009 71 78
8. D. Hildick-Smith, A.J. de Belder, and N. Cooter Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies Circulation 121 2010 1235 1243
9. S.L. Chen, T. Santoso, and J.J. Zhang A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) Trial J Am Coll Cardiol 57 2011 914 920
10. L. Ge, E. Tsagalou, and I. Iakovou In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent Am J Cardiol 95 2005 757 760 (Pubitemid 40332657)
11. A.R. Assali, H.V. Assa, and I. Ben-Dor Drug-eluting stents in bifurcation lesions: to stent one branch or both? Catheter Cardiovasc Interv 68 2006 891 896 (Pubitemid 44847095)
12. K. Tsuchida, A. Colombo, and T. Lefevre The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II) Eur Heart J 28 2007 433 442 (Pubitemid 47343573)
13. C. Di Mario, N. Morici, and C. Godino Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients Catheter Cardiovasc Interv 69 2007 416 424 (Pubitemid 46339286)
14. H.C. Gwon, S.H. Choi, and Y.B. Song Long-term clinical results and predictors of adverse outcomes after drug-eluting stent implantation for bifurcation lesions in a real-world practice: the COBIS (Coronary Bifurcation Stenting) registry Circ J 74 2010 2322 2328
15. K. Kozuma, Y. Ota, and Y. Nagai Clinical and angiographic outcomes with sirolimus-eluting stent for coronary bifurcation lesions. The J-PMS study Circ J 75 2011 306 314
16. T. Tamura, T. Kimura, and T. Morimoto Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach EuroIntervention 7 2011 588 596
17. A.R. Assali, H. Vaknin-Assa, and E. Lev Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy Catheter Cardiovasc Interv 79 2012 615 622
18. G. Niccoli, G. Ferrante, and I. Porto Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents Int J Cardiol 139 2008 80 91
19. S.S. Brar, W.A. Gray, and G. Dangas Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials EuroIntervention 5 2009 475 484
20. A. Hakeem, F.M. Khan, and S. Bhatti Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials J Invasive Cardiol 21 2009 589 595
21. D.G. Katritsis, G.C. Siontis, and J.P. Ioannidis Double versus single stenting for coronary bifurcation lesions: a meta-analysis Circ Cardiovasc Interv 2 2009 409 415
22. F. Zhang, L. Dong, and J. Ge Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials Heart 95 2009 1676 1681
23. G. Athappan, T. Ponniah, and L. Jeyaseelan True coronary bifurcation lesions: meta-analysis and review of literature J Cardiovasc Med (Hagerstown) 11 2010 103 110
24. M.W. Behan, N.R. Holm, and N.P. Curzen Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study Circ Cardiovasc Interv 4 2011 57 64
25. P. Zamani, and S. Kinlay Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: an observational meta-analysis Catheter Cardiovasc Interv 77 2011 202 212
26. W.J. Cheng, Y.J. Zhou, and Y.X. Zhao [Randomized study on T stenting and small protrusion technique versus simple stenting for patients with coronary artery bifurcation lesions and with big size side branch] Zhonghua Xin Xue Guan Bing Za Zhi 38 2010 131 134
27. Z. Gao, Y.J. Yang, and R.L. Gao Comparative study of simple versus complex stenting of coronary artery bifurcation lesions in daily practice in Chinese patients Clin Cardiol 31 2008 317 322 (Pubitemid 352040154)
28. A. Medina, J. Suarez de Lezo, and M. Pan [A new classification of coronary bifurcation lesions] Rev Esp Cardiol 59 2006 183
29. E. Walker, A.V. Hernandez, and M.W. Kattan Meta-analysis: Its strengths and limitations Cleve Clin J Med 75 2008 431 439
30. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12 (Pubitemid 26120810)
31. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available at: http://wwwohrica/programs/clinical-epidemiology/oxfordhtm. Accessed December 5, 2012.
32. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
33. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558 (Pubitemid 34746062)
34. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
35. M. Zimarino, A.M. Calafiore, and R. De Caterina Complete myocardial revascularization: between myth and reality Eur Heart J 26 2005 1824 1830 (Pubitemid 41253293)
36. A. Chieffo, N. Morici, and F. Maisano Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience Circulation 113 2006 2542 2547 (Pubitemid 43948033)
37. A.J. White, G. Kedia, and J.M. Mirocha Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis J Am Coll Cardiol Intv 1 2008 236 245 (Pubitemid 351816792)
38. L. Thuesen, H. Kelbaek, and L. Klovgaard Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT) Am Heart J 152 2006 1140 1145 (Pubitemid 44872987)
39. B.X. Chen, F.Y. Ma, and W. Luo Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography Heart 94 2008 566 570 (Pubitemid 351580126)
40. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 122
41. E.J. Armstrong, K.K. Yeo, and U. Javed Angiographic stent thrombosis at coronary bifurcations: short- and long-term prognosis J Am Coll Cardiol Intv 5 2012 57 63
42. P.J. Easterbrook, J.A. Berlin, R. Gopalan, and D.R. Matthews Publication bias in clinical research Lancet 337 1991 867 872
43. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
44. C. Tamburino, P. Capranzano, and D. Capodanno Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation J Am Coll Cardiol Intv 3 2010 624 631
45. Y. Louvard, M. Thomas, and V. Dzavik Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheter Cardiovasc Interv 71 2008 175 183 (Pubitemid 351293761)
46. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
47. H.C. Gwon, J.Y. Hahn, and B.K. Koo Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: results from the COBIS registry Heart 98 2012 225 231
48. G. Sarno, B. Lagerqvist, and O. Frobert Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR) Eur Heart J 33 2012 606 613
49. M. Zimarino, G. Renda, and R. De Caterina Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents Drugs 65 2005 725 732 (Pubitemid 40593622)
50. S.D. Wiviott, E. Braunwald, and C.H. McCabe Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial Lancet 371 2008 1353 1363
51. C.P. Cannon, R.A. Harrington, and S. James Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 2010 283 293